205 related articles for article (PubMed ID: 7608141)
21. GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
Wieser R; Wrana JL; Massagué J
EMBO J; 1995 May; 14(10):2199-208. PubMed ID: 7774578
[TBL] [Abstract][Full Text] [Related]
22. Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.
Ebner R; Chen RH; Lawler S; Zioncheck T; Derynck R
Science; 1993 Nov; 262(5135):900-2. PubMed ID: 8235612
[TBL] [Abstract][Full Text] [Related]
23. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
Wikström P; Bergh A; Damber JE
Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
25. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands.
Lin HY; Moustakas A; Knaus P; Wells RG; Henis YI; Lodish HF
J Biol Chem; 1995 Feb; 270(6):2747-54. PubMed ID: 7852346
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta receptor expression in human cornea.
Joyce NC; Zieske JD
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1922-8. PubMed ID: 9331255
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of transforming growth factor-beta receptors: cooperativity between the types I, II, and III receptors and modulation at the cell surface.
Zwaagstra JC; Kassam Z; O'Connor-Mccourt MD
Exp Cell Res; 1999 Nov; 252(2):352-62. PubMed ID: 10527625
[TBL] [Abstract][Full Text] [Related]
29. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells.
Periyasamy S; Sun L; Gentry LE; Brattain MG
J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926
[TBL] [Abstract][Full Text] [Related]
30. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
[TBL] [Abstract][Full Text] [Related]
31. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest.
Zwaagstra JC; Guimond A; O'Connor-McCourt MD
Exp Cell Res; 2000 Jul; 258(1):121-34. PubMed ID: 10912794
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
33. Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription.
Brand T; Schneider MD
J Biol Chem; 1995 Apr; 270(14):8274-84. PubMed ID: 7713935
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
Hypes MK; Pirisi L; Creek KE
Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta receptors-I and -II immunoexpression in Alzheimer's disease: a comparison with aging and progressive supranuclear palsy.
Lippa CF; Flanders KC; Kim ES; Croul S
Neurobiol Aging; 1998; 19(6):527-33. PubMed ID: 10192211
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
38. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
[TBL] [Abstract][Full Text] [Related]
39. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
Fanayan S; Firth SM; Baxter RC
J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins.
Tam BY; Philip A
J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
